{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:10:29Z","timestamp":1783426229362,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,27]]},"DOI":"10.7759\/cureus.29657","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T17:30:45Z","timestamp":1664299845000},"source":"Crossref","is-referenced-by-count":11,"title":["A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Chowdhury F","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakia","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proma","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Mustarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuzhat","family":"Tamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selia","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farjana","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Sakibuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyata","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.30121","article-title":"Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates","volume":"15","author":"Ullah R","year":"2019","unstructured":"Ullah R, Rauf N, Nabi G, Ullah H, Shen Y, Zhou YD, Fu J. Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates. Int J Biol Sci. 2019, 15:265-76. 10.7150\/ijbs.30121","journal-title":"Int J Biol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i2.163","article-title":"Current status, problems, and perspectives of non-alcoholic fatty liver disease research","volume":"25","author":"Tanaka N","year":"2019","unstructured":"Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol. 2019, 25:163-77. 10.3748\/wjg.v25.i2.163","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190119113836","article-title":"Genetics of nonalcoholic fatty liver disease: a 2018 update","volume":"24","author":"Valenti LV","year":"2018","unstructured":"Valenti LV, Baselli GA. Genetics of nonalcoholic fatty liver disease: a 2018 update. Curr Pharm Des. 2018, 24:4566-73. 10.2174\/1381612825666190119113836","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi ZM","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019, 70:531-44. 10.1016\/j.jhep.2018.10.033","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190117114305","article-title":"The role of statins in the management of nonalcoholic fatty liver disease","volume":"24","author":"Doumas M","year":"2018","unstructured":"Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG. The role of statins in the management of nonalcoholic fatty liver disease. Curr Pharm Des. 2018, 24:4587-92. 10.2174\/1381612825666190117114305","journal-title":"Curr Pharm Des"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa P","year":"2017","unstructured":"Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int. 2017, 37:85-9. 10.1111\/liv.13301","journal-title":"Liver Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i17.3150","article-title":"Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease","volume":"23","author":"Gelli C","year":"2017","unstructured":"Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol. 2017, 23:3150-62. 10.3748\/wjg.v23.i17.3150","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1844-5","article-title":"Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria","volume":"58","author":"Schwenger KJ","year":"2019","unstructured":"Schwenger KJ, Bolzon CM, Li C, Allard JP. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. Eur J Nutr. 2019, 58:1771-84. 10.1007\/s00394-018-1844-5","journal-title":"Eur J Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.101215","article-title":"NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment","volume":"47","author":"Targher G","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metab. 2021, 47:101215. 10.1016\/j.diabet.2020.101215","journal-title":"Diabetes Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0239","article-title":"Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"27","author":"Wijarnpreecha K","year":"2021","unstructured":"Wijarnpreecha K, Aby ES, Ahmed A, Kim D. Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2021, 27:221-35. 10.3350\/cmh.2020.0239","journal-title":"Clin Mol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher G","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021, 6:578-88. 10.1016\/S2468-1253(21)00020-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190117100751","article-title":"Nonalcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"24","author":"Macut D","year":"2018","unstructured":"Macut D, Bjeki\u0107-Macut J, Livadas S, et al.. Nonalcoholic fatty liver disease in patients with polycystic ovary syndrome. Curr Pharm Des. 2018, 24:4593-7. 10.2174\/1381612825666190117100751","journal-title":"Curr Pharm Des"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001679","article-title":"Non-alcoholic fatty liver disease in inflammatory bowel disease patients","volume":"32","author":"Karaivazoglou K","year":"2020","unstructured":"Karaivazoglou K, Konstantakis C, Tourkochristou E, Assimakopoulos SF, Triantos C. Non-alcoholic fatty liver disease in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol. 2020, 32:903-6. 10.1097\/MEG.0000000000001679","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts","volume":"24","author":"Papatheodoridi M","year":"2018","unstructured":"Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts. Curr Pharm Des. 2018, 24:4574-86. 10.2174\/1381612825666190117102111","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1040-1","article-title":"Current and emerging therapies for non-alcoholic fatty liver disease","volume":"79","author":"Patel SS","year":"2019","unstructured":"Patel SS, Siddiqui MS. Current and emerging therapies for non-alcoholic fatty liver disease. Drugs. 2019, 79:75-84. 10.1007\/s40265-018-1040-1","journal-title":"Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.03.019","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: a comprehensive systematic review and meta-analysis","volume":"15","author":"Singh A","year":"2021","unstructured":"Singh A, Hussain S, Antony B. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: a comprehensive systematic review and meta-analysis. Diabetes Metab Syndr. 2021, 15:813-22. 10.1016\/j.dsx.2021.03.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13338","article-title":"COVID-19 and non-alcoholic fatty liver disease: two intersecting pandemics","volume":"50","author":"Portincasa P","year":"2020","unstructured":"Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A. COVID-19 and non-alcoholic fatty liver disease: two intersecting pandemics. Eur J Clin Invest. 2020, 50:e13338. 10.1111\/eci.13338","journal-title":"Eur J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice","volume":"25","author":"Zhou JH","year":"2019","unstructured":"Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 2019, 25:1307-26. 10.3748\/wjg.v25.i11.1307","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease\u2014the known, the unknown, and the future","volume":"28","author":"Lang S","year":"2020","unstructured":"Lang S, Schnabl B. Microbiota and fatty liver disease\u2014the known, the unknown, and the future. Cell Host Microbe. 2020, 28:233-44. 10.1016\/j.chom.2020.07.007","journal-title":"Cell Host Microbe"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14521","article-title":"A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications\u2014what the non-specialist needs to know","volume":"24","author":"Muthiah MD","year":"2022","unstructured":"Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications\u2014what the non-specialist needs to know. Diabetes Obes Metab. 2022, 24:3-14. 10.1111\/dom.14521","journal-title":"Diabetes Obes Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0065","article-title":"Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease","volume":"183","author":"Ruissen MM","year":"2020","unstructured":"Ruissen MM, Mak AL, Beuers U, Tushuizen ME, Holleboom AG. Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. Eur J Endocrinol. 2020, 183:R57-73. 10.1530\/EJE-20-0065","journal-title":"Eur J Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021, 18:e1003583. 10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018, 67:328-57. 10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.30699\/ijp.2017.25038","article-title":"Clinical manifestations and diagnosis of non-alcoholic fatty liver disease","volume":"12","author":"Khoonsari M","year":"2017","unstructured":"Khoonsari M, Mohammad Hosseini Azar M, Ghavam R, et al.. Clinical manifestations and diagnosis of non-alcoholic fatty liver disease. Iran J Pathol. 2017, 12:99-105. 10.30699\/ijp.2017.25038","journal-title":"Iran J Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8684-7_2","article-title":"Epidemiology and etiologic associations of non-alcoholic fatty liver disease and associated HCC","volume":"1061","author":"Liu K","year":"2018","unstructured":"Liu K, McCaughan GW. Epidemiology and etiologic associations of non-alcoholic fatty liver disease and associated HCC. Adv Exp Med Biol. 2018, 1061:3-18. 10.1007\/978-981-10-8684-7_2","journal-title":"Adv Exp Med Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo A","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, et al.. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019, 70:1457-69. 10.1002\/hep.30626","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665119000570","article-title":"From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis","volume":"78","author":"Moore JB","year":"2019","unstructured":"Moore JB. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. Proc Nutr Soc. 2019, 78:290-304. 10.1017\/S0029665119000570","journal-title":"Proc Nutr Soc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and its management","volume":"35","author":"Mundi MS","year":"2020","unstructured":"Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. Evolution of NAFLD and its management. Nutr Clin Pract. 2020, 35:72-84. 10.1002\/ncp.10449","journal-title":"Nutr Clin Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8684-7_5","article-title":"NAFLD related-HCC: the relationship with metabolic disorders","volume":"1061","author":"Zhang X","year":"2018","unstructured":"Zhang X. NAFLD related-HCC: the relationship with metabolic disorders. Adv Exp Med Biol. 2018, 1061:55-62. 10.1007\/978-981-10-8684-7_5","journal-title":"Adv Exp Med Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.03.016","article-title":"Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors","volume":"12","author":"Al-Dayyat HM","year":"2018","unstructured":"Al-Dayyat HM, Rayyan YM, Tayyem RF. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes Metab Syndr. 2018, 12:569-75. 10.1016\/j.dsx.2018.03.016","journal-title":"Diabetes Metab Syndr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter TG","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020, 158:1851-64. 10.1053\/j.gastro.2020.01.052","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0009.6003","article-title":"Impact of bariatric surgery on non-alcoholic fatty liver disease","volume":"89","author":"Major P","year":"2017","unstructured":"Major P, P\u0119dziwiatr M, Rubinkiewicz M, et al.. Impact of bariatric surgery on non-alcoholic fatty liver disease. Pol Przegl Chir. 2017, 89:1-4. 10.5604\/01.3001.0009.6003","journal-title":"Pol Przegl Chir"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni S","year":"2018","unstructured":"Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018, 24:3361-73. 10.3748\/wjg.v24.i30.3361","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.08.005","article-title":"The future of nonalcoholic fatty liver disease treatment","volume":"103","author":"Mazhar K","year":"2019","unstructured":"Mazhar K. The future of nonalcoholic fatty liver disease treatment. Med Clin North Am. 2019, 103:57-69. 10.1016\/j.mcna.2018.08.005","journal-title":"Med Clin North Am"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri BA","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017, 15:45. 10.1186\/s12916-017-0806-8","journal-title":"BMC Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i42.7327","article-title":"Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver","volume":"19","author":"Rojas-Feria M","year":"2013","unstructured":"Rojas-Feria M, Castro M, Su\u00e1rez E, Ampuero J, Romero-G\u00f3mez M. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol. 2013, 19:7327-40. 10.3748\/wjg.v19.i42.7327","journal-title":"World J Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran B","year":"2018","unstructured":"Kumarendran B, O'Reilly MW, Manolopoulos KN, et al.. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018, 15:e1002542. 10.1371\/journal.pmed.1002542","journal-title":"PLoS Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57101057","article-title":"Non-alcoholic fatty liver disease and COVID-19-two pandemics hitting at the same time","volume":"57","author":"Vrani\u0107 L","year":"2021","unstructured":"Vrani\u0107 L, Radovan A, Poropat G, Mikola\u0161evi\u0107 I, Mili\u0107 S. Non-alcoholic fatty liver disease and COVID-19-two pandemics hitting at the same time. Medicina (Kaunas). 2021, 57:1057. 10.3390\/medicina57101057","journal-title":"Medicina (Kaunas)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01564-z","article-title":"Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management","volume":"20","author":"Xu Y","year":"2021","unstructured":"Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis. 2021, 20:126. 10.1186\/s12944-021-01564-z","journal-title":"Lipids Health Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-020-01021-2","article-title":"Treatment of non-alcoholic fatty liver disease \u2014 current perspectives","volume":"39","author":"Elhence A","year":"2020","unstructured":"Elhence A, Shalimar. Treatment of non-alcoholic fatty liver disease \u2014 current perspectives. Indian J Gastroenterol. 2020, 39:22-31. 10.1007\/s12664-020-01021-2","journal-title":"Indian J Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13676","article-title":"Future therapy for non-alcoholic fatty liver disease","volume":"38","author":"Issa D","year":"2018","unstructured":"Issa D, Patel V, Sanyal AJ. Future therapy for non-alcoholic fatty liver disease. Liver Int. 2018, 38:56-63. 10.1111\/liv.13676","journal-title":"Liver Int"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12751","article-title":"What are the main areas of focus to prevent or treat non-alcoholic fatty liver disease?","volume":"20","author":"Mansour A","year":"2019","unstructured":"Mansour A, Hekmatdoost A, Mirmiran P. What are the main areas of focus to prevent or treat non-alcoholic fatty liver disease?. J Dig Dis. 2019, 20:271-7. 10.1111\/1751-2980.12751","journal-title":"J Dig Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan MC","year":"2013","unstructured":"Ryan MC, Itsiopoulos C, Thodis T, et al.. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013, 59:138-43. 10.1016\/j.jhep.2013.02.012","journal-title":"J Hepatol"},{"key":"ref44","article-title":"Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the \u201cplague\u201d of the 21st century? A literature review focusing on pathogenesis, prevention and treatment","volume":"22","author":"Argyrou C","year":"2017","unstructured":"Argyrou C, Moris D, Vernadakis S. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the \u201cplague\u201d of the 21st century? A literature review focusing on pathogenesis, prevention and treatment. J BUON. 2017, 22:6-20.","journal-title":"J BUON"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4085-6","article-title":"Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD","volume":"61","author":"Reeves HL","year":"2016","unstructured":"Reeves HL, Zaki MY, Day CP. Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci. 2016, 61:1234-45. 10.1007\/s10620-016-4085-6","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114893-a-multidisciplinary-approach-and-current-perspective-of-nonalcoholic-fatty-liver-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:56Z","timestamp":1707508136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114893-a-multidisciplinary-approach-and-current-perspective-of-nonalcoholic-fatty-liver-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.29657","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}